Dr. Sawhney completed his MBBS in 1980 and exhibited academic excellence during his academic years with five gold medals and Pfizer’s Gold Medal for Post graduation in Medicine. Dr JPS Sawhney is the senior consultant cardiologist, chairman department of cardiology and member board of management at Sir Gangaram hospital at New Delhi, India. He is also Ex member of Delhi Medical Council.
He is a fellow of Royal College of Physicians (FRCP), American College of Cardiology (FACC), European society of cardiology (FESC) and member of American Heart association, European society of Heart failure and European Society of Preventive cardiology and European Atherosclerosis society. He also chaired the Lipid Council of India, Cardiological society of India.
His area of interest is clinical and preventive cardiology. He has done pioneering work in heart attacks in young Indians and Familial Hypercholesterolemia. He has been a pioneer in initiating global clinical trials and national and International registries especially Atrial Fibrillation, Heart Failure and Acute Coronary Syndrome Registry. Along with being Principal Investigator and National Coordinator to global landmark trials he has authored many articles in journals and chapters in books of national and international repute. His pioneering work also includes promotion of group practice to improve patient care and to develop medical sub-specialties. He is actively involved in Rotary Club and is Paul Harris Fellow. Since college days he is active player and enthusiast of cricket.
Publications & Research With Weblinks
1. Fox Kaa, Virdone S, Bassand J-P, Et Al. Do Baseline Characteristics And Treatments Account For Geographical Disparities In The Outcomes Of Patients With Newly Diagnosed Atrial Fibrillation?The Prospective Garfield-Af Registry. Bmj Open 2022;12:E049933, Doi: 10.1136/Bmjopen-2021-049933
2. Angiotensin Receptor-Neprilysin Inhibitor Therapy And Cardiac Remodeling In Heart Failure: Consensus Statement From India. Japi 2023.73-82 Https://Europepmc.Org/Article/Med/37355795
3. Sawhney Jp, Jain P, Kantanavar K. Management Of Heart Failure Patients With Systolic Dysfunction In A Real-World Setting-A Physician-Based Survey. Int J Adv Med 2023;10:527-37.
4. Jamshed Dalal, J. P. Sawhney, P. B. Jayagopal, P. K. Hazra, Mohammed Yunus Khan, Kumar Gaurav, Colette Pinto, Amey Mane, Sachin Rao, Madhur Jain, "A Retrospective, Observational, Emr-Based Real-World Evidence Study To Assess The Incidence Of Pedal Edema In Essential Hypertensive Patients On Amlodipine Or Cilnidipine", International Journal Of Hypertension, Vol. 2022, Article Id 6868143, 9 Pages, 2022. Https://Www.Hindawi.Com/Journals/Ijhy/2022/6868143/
5. Hiremath J, Mohan Jc, Hazra P, Sawhney Js, Mehta A, Shetty S, Et Al. Bempedoic Acid For Lipid Management In The Indian Population: An Expert Opinion. Cureus. 2023 Feb 24;15(2):E35395.Https://Assets.Cureus.Com/Uploads/Review_Article/Pdf/138419/20230326-4575-1t3t1mh.Pdf /p>
6. Dalal Jj, Kerkar P, Guha S, Dasbiswas A, Sawhney Jps, Natarajan S, Maddury Sr, Kumar As, Chandra N, Suryaprakash G, Thomas Jm, Juvale Ni, Sathe S, Khan A, Bansal S, Kumar V, Reddi R. Therapeutic Adherence In Hypertension: Current Evidence And Expert Opinion From India. Indian Heart J. 2021;73(6):667-673. Https://Www.Sciencedirect.Com/Science/Article/Pii/S0019483221001905
7. Immaneni Sathyamurthy, Ms Hiremath, Jitendra Pal Sawhney, Subhash Chandra, Hrudanand Mishra, Ck Ponde, Et Al. Expert Opinion On P2y12 Inhibitors Use In Management Of Acute Coronary Syndromes: Focus On Ticagrelor. Japi: 69, 2021:75-81. Https://Europepmc.Org/Article/Med/34781659
8. Jps Sawhney, Kushal Madan. Family-Based Approach In Cardiovascular Risk Reduction. The Lancet Global Health, Volume 9, Issue 10, 2021, Pages E1351-E1352.
9. Bassand Jp, Apenteng Pn, Atar D, Camm Aj, Cools F, Corbalan R, Fitzmaurice Da, Fox Ka, Goto S, Haas S, Hacke W, Jerjes-Sanchez C, Koretsune Y, Heuzey Jl, Sawhney Jp, Oh S, Stępińska J, Cate Vt, Verheugt Fw, Kayani G, Pieper Ks, Kakkar Ak, Garfield-Af Investigators Ft. Garfield-Af: A Worldwide Prospective Registry Of Patients With Atrial Fibrillation At Risk Of Stroke.Future Cardiol. 2021 Jan;17(1):19-38.
10. Setia N, Movva S, Balakrishnan P, Biji Ik, Sawhney Jps, Puri R, Arora A, Puri Rd, Saxena R, Mishra S, Apte S, Kulshrestha S, Ramprasad Vl, Verma Ic. Genetic Analysis Of Familial Hypercholesterolemia In Asian Indians: A Single-Center Study. J Clin Lipidol. 2020 Jan-Feb;14(1):35-45. Https://Www.Sciencedirect.Com/Science/Article/Abs/Pii/S1933287419303708
11. Huo Y, Lee Sw, Sawhney Jps, Kim Hs, Krittayaphong R, Pocock Sj, Nhan Vt, Alonso-Garcia Á, Chin Ct, Jiang J, Jan S, Vega Am, Hayashi N, Ong Tk. Two-Year Outcomes Post-Discharge In Asian Patients With Acute Coronary Syndrome: Findings From The Epicor Asia Study. Int J Cardiol. 2020 Sep 15;315:1-8. Https://Www.Sciencedirect.Com/Science/Article/Abs/Pii/S0167527319342123
12. Zheng B, Huo Y, Lee Sw, Sawhney Jps, Kim Hs, Krittayaphong R, Pocock Sj, Nhan Vt, Alonso Garcia A, Chin Ct, Jiang J, Jan S, Vega Am, Hayashi N, Ong Tk. Long-Term Antithrombotic Management Patterns In Asian Patients With Acute Coronary Syndrome: 2-Year Observations From The Epicor Asia Study. Clin Cardiol. 2020 Sep;43(9):999-1008. Https://Onlinelibrary.Wiley.Com/Doi/Full/10.1002/Clc.23400
13. Ouwerkerk W, Teng Tk, Tromp J, Tay Wt, Cleland Jg, Van Veldhuisen Dj, Dickstein K, Ng Ll, Lang Cc, Anker Sd, Zannad F, Hung Cl, Sawhney Jps, Naik A, Shimizu W, Hagiwara N, Wander Gs, Anand I, Richards Am, Voors Aa, Lam Csp. Effects Of Combined Renin-Angiotensin-Aldosterone System Inhibitor And Beta-Blocker Treatment On Outcomes In Heart Failure With Reduced Ejection Fraction: Insights From Biostat-Chf And Asian-Hf Registries. Eur J Heart Fail. 2020 Aug;22(8):1472-1482. Https://Onlinelibrary.Wiley.Com/Doi/Full/10.1002/Ejhf.1869
14. Zhang S, Wang W, Sawhney Jps, Krittayaphong R, Kim Hs, Nhan Vt, Lee Sw, Ong Tk, Chin Ct, Pocock Sj, Huo Y, Qian J, Ge J. Antithrombotic Management And Long-Term Outcomes Following Percutaneous Coronary Intervention For Acute Coronary Syndrome In Asia. Int J Cardiol. 2020 Jul 1;310:16-22. Https://Www.Sciencedirect.Com/Science/Article/Abs/Pii/S0167527319348545
15. Thacker H, Konda Reddy Km, Murthy Ls, Sawhney Jp, Chaudhary G, Shah S, Joseph S, Rajarshi M, Nikam P. Blood-Pressure Lowering Efficacy And Safety Of Perindopril / Indapamide / Amlodipine Single-Pill Combination In Hypertensive Patients: Phase Iii Trial In India. J Assoc Physicians India. 2020 Oct;68(10):39-43. Doi: 10.1097/Hjh.0000000000001359
16. Dalal J, Sethi Kk, Guha S, Ray S, Deb Pk, Kirpalani A, Rao Maddury S, Sathyamurthy I, Shah S, Das Mk, Chandalia Hb, Sawhney J, Thomas J, Kumar V, Chandra N, Khan A, Kumar As, Suryaprakash G.Screening For Hypertension In Asymptomatic Individuals In India: An Expert Consensus Statement. J Assoc Physicians India. 2020 Apr;68(4):73-79. Https://Europepmc.Org/Article/Med/32610855
17. Sawhney Jps, Dalal J, A M, Bansal S, Kahali D, Therapeutic Experience Of Ticagrelor In Indian Patients With Acute Coronary Syndrome: A Non-Interventional, Prospective, Observational Study, Indian Heart Journal,2019, Https://Doi.Org/10.1016/J.Ihj.2019.08.001.
18. Jps Sawhney, Shashi Ranjan Prasad, Manish Sharma, Kushal Madan, A Mohanty , Rajiv Passey , Ashwani Mehta, B Kandpal , Aman Makhija , Rajneesh Jain , Rr Mantri , Bhola Shankar Vivek, Sc Manchanda , Ic Verma. Prevalence Of Familial Hypercholesterolemia In Premature Coronary Artery Disease Patients Admitted To A Tertiary Care Hospital In North India. Indian Heart J. 2019 Mar - Apr;71(2):118-122. Https://Www.Sciencedirect.Com/Science/Article/Pii/S0019483218311052
19. Goto S, Angchaisuksiri P, Bassand Jp, Camm Aj, Dominguez H, Illingworth L, Gibbs H, Goldhaber Sz, Goto S, Jing Zc, Haas S, Kayani G, Koretsune Y, Lim Tw, Oh S, Sawhney Jps, Turpie Agg, Van Eickels M, Verheugt Fwa, Kakkar Ak Garfield‐Af Investigators. Management And 1-Year Outcomes Of Patients With Newly Diagnosed Atrial Fibrillation And Chronic Kidney Disease: Results From The Prospective Garfield - Af Registry. J Am Heart Assoc. 2019 Feb 5;8(3):E010510. Https://Www.Ahajournals.Org/Doi/Full/10.1161/Jaha.118.010510
20. Apaar Dadlani, Kushal Madan, Jps Sawhney. Ambulatory Blood Pressure Monitoring In Clinical Practice. Indian Heart Journal. 2019 ;71(1):91-97. Https://Www.Sciencedirect.Com/Science/Article/Pii/S0019483218305753
21. Deepak Agrawal, , S.C. Manchanda, J.P.S. Sawhney, , Bhuwanesh Kandpal, Rajneesh Jain, Ashwani Mehta, , Arun Mohanty, Rajiv Passey, Aman Makhija, Manish Kr. Sharma. To Study The Effect Of High Dose Atorvastatin 40 Mg Versus 80 Mg In Patients With Dyslipidemia. Indian Heart Journal, 2018-12-01, Volume 70, Pages S8-S12. Https://Www.Sciencedirect.Com/Science/Article/Pii/S0019483217305321
22. Rishabh Khurana, Anurag Yadav, T.B.S. Buxi, J.P.S. Sawhney, Kishan Singh Rawat, Samarjit S. Ghuman. Correlation Of Epicardial Fat Quantification With Severity Of Coronary Artery Disease: A Study In Indian Population Indian Heart Journal, 2018-12-01, Volume 70, Pages S140-S145 Https://Www.Sciencedirect.Com/Science/Article/Pii/S0019483218303894
23. Chanchal Chandramouli, Wan Ting Tay, ; Nurul Sahiddah Bamadhaj, Jasper Tromp, Tiew-Hwa Katherine Teng, Jonathan Jl Yap, Michael R Macdonald,Chung-Leih Hung, Koen Streng, Ajay Naik, Gurpreet Singh Wander, Jitendra Sawhney, Lieng Hsi Ling, A.Mark Richards, Inder Anand, Adriaan A. Voors, Carolyn Sp Lam. On Behalf Of Asian-Hf Investigators.Association Of Obesity With Heart Failure Outcomes In Asia: A Cohort Study. 2019. Plos Medicine
24. Arya V, Mahajan P, Saraf A, Mohanty A, Sawhney Jp, Bhargava M. Association Of Cyp2c19, Cyp3a5 And Gpiib/Iiia Gene Polymorphisms With Aspirin And Clopidogrel Resistance In A Cohort Of Indian Patients With Coronary Artery Disease. Int J Lab Hematol. 2015 Aug 12. Doi: 10.1111/Ijlh.12416. Https://Onlinelibrary.Wiley.Com/Doi/Abs/10.1111/Ijlh.12416
25. Pahlajani D, Kaul U, Mishra A, Mullasari A, Sawhney J, Dargad R, Mehta K, Brar S, Radhakrishnan R, Mcmahon D, Ibrahim S, Sachanandani H, Sinha N.Medical Management And Diagnostic Testing Among Stable Angina Patients In India: The Stable Angina Observational (Star) Registry. J Assoc Physicians India. 2015;63(9):20-6. Https://Www.Researchgate.Net/Profile/Mullasari-Ajit-Sankardas/Publication/282937555_Medical_Management_And_Diagnostic_Testing_Among_Stable_Angina_Patients_In_India_The_Stable_Angina_Observational_Star_Registry/Links/562b099b08aef25a24404f16/Medical-Management-And-Diagnostic-Testing-Among-Stable-Angina-Patients-In-India-The-Stable-Angina-Observational-Star-Registry.Pdf
26. Huo Y, Lee Sw, Sawhney Jp, Kim Hs, Krittayaphong R, Nhan Vt, Alonso-Garcia A, Han Yl, Ge J, Chin Ct, Ong Tk, Jan S, Itoh Y, Vega Am, Pocock S. Rationale, Design, And Baseline Characteristics Of The Epicor Asia Study (Long-Term Follow-Up Of Antithrombotic Management Patterns In Acute Coronary Syndrome Patients In Asia). Clin Cardiol. 2015 Jul 24. Doi: 10.1002/Clc.22431 Https://Onlinelibrary.Wiley.Com/Doi/Full/10.1002/Clc.22431
27. Sathyamurthy I, Dalal Jj, Sawhney Jp, Mohan Jc, Chogle Sa, Desai N, Sathe Sp, Maisel As. Cardiac Biomarkers For Better Management Of Acute Coronary Syndromes. J Assoc Physicians India. 2015 Jun; 63(6):46-50.
28. Sharma M, Sawhney Jp, Panda S. Sleep Quality And Duration – Potentially Modifiable Risk Factors For Coronary Artery Disease? Indian Heart J. 2014 Nov-Dec;66(6):565-8. Https://Www.Sciencedirect.Com/Science/Article/Pii/S0019483214007111
29. Sarat Chandra K, Bansal M, Nair T, Iyengar Ss, Gupta R, Manchanda Sc, Mohanan Pp, Dayasagar Rao V, Manjunath Cn, Sawhney Jp, Sinha N, Pancholia Ak, Mishra S, Kasliwal Rr, Kumar S, Krishnan U, Kalra S, Misra A, Shrivastava U, Gulati S. Consensus Statement On Management Of Dyslipidemia In Indian Subjects. Indian Heart J. 2014 Dec;66 Suppl 3:S1-S51. Https://Www.Ncbi.Nlm.Nih.Gov/Pmc/Articles/Pmc4297876/
30. Madan K, Babu As, Contractor A, Sawhney Jp, Prabhakaran D, Gupta R. Cardiac Rehabilitation In India. Prog Cardiovasc Dis. 2014 Mar-Apr;56(5):543-50. Https://Www.Sciencedirect.Com/Science/Article/Abs/Pii/S0033062013002338
Chapters In Books:
1. Ss Iyengar, Jps Sawhney. Guidelines: What To Adopt ? In: Ss Iyenger, Rr Kasliwal Editors. Practical Guide To Managing Hypertension. Elsevier; 2010. Page 1-10.
2. Jps Sawhney. Management Of Dyslipidemia In Difficult Clinical Situations. In: Jamshed J.Dalal, H.M.Mardikar Editors. Cad Update 2013. Cardio Vascular Society Of India. Elsevier; 2013. Page.85-96.
3. Kushal Madan, Jps Sawhney. Cardiac Rehabilitation The Forgotten Therapeutic Option. In: K Venugopal Editor. Cardiological Society Of India Update Book 2013. Page 199-207.
4. Jps Sawhney. History Of Ace-Inhibitors. In: Hk Chopra, Navin C Nanda Editors. Textbook Of Cardiology A Clinical & Historical Perspective. Jaypee; 2013. Page 73-75.
5. Kushal Madan, Jps Sawhney. “Post Mi: Risk Stratification And Cardiac Rehabilitation.” In: H K Chopra Editor. Cardiological Society Of India Update Book 2014.
6. Jps Sawhney, Dileep K Tiwari, Simran Sawhney. Statins And New Guidelines – Are They Relevant To Indian Population ? In: Jamshed J.Dalal, N Deshpande, H.M.Mardikar Editors. Cad Update 2014. Cardio Vascular Society Of India. Elsevier; 2014. Page.59-69.
7. Jps Sawhney. “Cardiac Rehabilitation After Stemi”. In: H K Chopra Editor. Stemi Update 2015.Page 1242-1247.
8. Jps Sawhney, Tanushree Pal. “Telmisartan: Relevance Of Choice Of Formulation In The Setting Of Stemi”. In: H K Chopra Editor. Stemi Update 2015. Page 541-548.
9. Jps Sawhney, Saurabh Bagga, Simran Sawhney. “Newer Modalities Of Ldl Lowering”. Cardiological Society Of India Update Book 2015. Page 24-30.
10. Jps Sawhney, Saurabh Bagga,Kushal Madan. “Cardiac Rehabilitation In Coronary Artery Diseae”. In: Shirish Hiremath Editor. Cardiological Society Of India Update Book 2016. Jaypee Brothers Medical Publishers (P) Ltd. Pages: 135-140.
11. J P S Sawhney, Kaushal Gandhi, Saurabh Bagga, Simran Sawhney. “Af Management Strategies In Medically Managed Acs”. In : Hk Chopra, Gs Wander, Praveen Chandra, Viveka Kumar Editors. Atrial Fibrillation Update A Textbook Of Cardiology. Jaypee Brothers Medical Publishers (P) Ltd. 2016. Pages:403-406.
12. Jps Sawhney, Simran Sawhney, Saurabh Bagga. Hypertension And Coronary Artery Disease. In: Ba Murugunathan (Eds.). Manual Of Hypertension, Hypertension Society Of India. Jaypee Brothers Medical Publishers (P) Ltd. 2016. Pages: 336-342.
13. Jps Sawhney. “What Is Heart Attack?” In: Jps Sawhney, Rajiv Passey, Atul Kakar, Samiran Nundy. Heart Attack. Elsevier. 2016. Pages: 1-7.
14. Jps Sawhney, Simran Sawhney, Saurabh Bagga. Familial Hypercholesterolemia In Routine Cardiac Practice: Recognition And Management. In Sarat Chandra K, Bansal M (Eds). Cardiology Update 2017. Cardiological Society Of India, Elsevier (Relx India Pvt Ltd), Gurgaon, India 2017. Pages: 109- 114. (Isbn: 978-81-312-5285-7).
15. Jps Sawhney, Kushal Madan, Simran Sawhney. Post Stemi Intervention Rehabilitation In Cardio Diabetes. In : Hk Chopra, Sr Joshi, Gs Wander, Rr Kasliwal, Viveka Kumar, Ak Pancholia Editors. Cardio Diabetes Update : Textbook Of Cardiology. Jaypee Brothers Medical Publishers (P) Ltd. 2017. Pages: 847-852.
16. Jps Sawhney, Arjun Sreekumar, Saurabh Bagga. Clinical Spectrum Of Cardiodiabetes: How Indians Are Different ? In : Hk Chopra, Sr Joshi, Gs Wander, Rr Kasliwal, Viveka Kumar, Ak Pancholia Editors. Cardio Diabetes Update : Textbook Of Cardiology. Jaypee Brothers Medical Publishers (P) Ltd. 2017. Pages: 3-6.
17. Jps Sawhney, Saurabh Bagga, Simran Sawhney. Hyperlipidemias: Focus On Familial Hypertryglyceridemia And Familial Hypercholesterolemia. In Sn Narasingan (Eds.). Monograph Lipidology In Clinical Practice. Jaypee Brothers Medical Publishers (P) Ltd.2017. Pages: 224-232.
18. Jps Sawhney, Kushal Madan. Alcohol & Cad: Fact Vs. Fiction. In Kc Goswami (Eds). Cardiology Update 2018. Cardiological Society Of India, 2018.
19. Jps Sawhney, Kushal Madan,Simran Sawhney, Shashi Ranjan. “Familial Hypercholesterolemia”. In Kk Pareek (Eds). Medicine Update 2019. Jaypee Brothers Medical Publishers (P) Ltd.
20. Jps Sawhney, Kushal Madan, Simran Sawhney. Cardiac Rehabilitation After Myocardial Infarction. In: Jamshed J.Dalal, (Eds.). Cad Update 2018. Cardio Vascular Society Of India. Pages 87-94
21. Jps Sawhney, Prashant Wankhade , Simran Sawhney. Lipid Evaluation: Diagnostic, Prognostic & Clinical Therapeutic Implications. In : Advances In Clinical Cardiovascular Imaging, Echocardiography & Interventions: Textbook Of Cardiology. H.K. Chopra, Navin C. Nanda, Jagat Narula (Eds.). Jaypee Brothers Medical Publishers (P) Ltd.2018. Pages: 1155-1161. /p>
22. Jps Sawhney. The Growing Presence Of India In Global Studies. In: Csi Textbook Of Cardiology The Indian Perspective. Prdip K Deb (Eds.). Jaypee Brothers Medical Publishers (P) Ltd.2018. Pages: 991-1001.
23. Vyom Mori, Simran Sawhney, Jps Sawhney. “Triglycerides And Cardiovascular Risk : Have We Reached A Consensus ?”. In: Pp Mohanan, Mn Krishnan (Eds.). Cardiology Update 2020. Cardiological Society Of India. Evangel Publishing.2020. Pages 74-77.
24. Jps Sawhney, Kushal Madan, Simran Sawhney. Air Pollution And Hypertension. In : H.K. Chopra, Navin C. Nanda, Jagat Narula, Gs Wander, Cn Manjunath, Praveen Chandra(Eds). Hypertension New Frontiers. Textbook Of Cardiology. Jaypee Brothers Medical Publishers (P) Ltd. 2021. Pages: 95-98.
25. Jps Sawhney, Viraj Suvarna, Hk Chopra. Power And Promise Of Home Bp Monitoring. In : H.K. Chopra, Navin C. Nanda, Jagat Narula, Gs Wander, Cn Manjunath, Praveen Chandra(Eds). Hypertension New Frontiers. Textbook Of Cardiology. Jaypee Brothers Medical Publishers (P) Ltd. 2021. Pages: 262-266.
26. Kushal Madan, Saurabh Bagga, Jps Sawhney. Exercise Training In Resistant Hypertension. In : H.K. Chopra, Navin C. Nanda, Jagat Narula, Gs Wander, Cn Manjunath, Praveen Chandra(Eds). Hypertension New Frontiers. Textbook Of Cardiology. Jaypee Brothers Medical Publishers (P) Ltd. 2021. Pages:936-938.
27. Jps Sawhney, Kushal Madan. Familial Hypercholesterolemia. In : Ck Ponde, Pp Mohanan. (Eds). Cardiology Edition : Lipids. Micro Labs Limited. 2021. Pages: 50-56.
28. Jps Sawhney, Vyom Mori, Kushal Madan. “Right Time For Initiating Intensive Combination Lipid Lowering Therapy In Atherosclerotic Cardiovascular Disease. In: Partha Sartha Banerjee (Editor). Cardiology Update 2021. Cardiological Society Of India. Evangel Publishing.2021. Pages 296-300.
29. Jps Sawhney, Ayush Kumar, Kushal Madan. Familial Hypercholesterolemia. In : H.K. Chopra, Navin C. Nanda, Jagat Narula, Gs Wander, Cn Manjunath, Praveen Chandra, Viveka Kumar, Ck Ponde, Ak Pancholia (Eds). Advances In Statin Therapy & Beyond In Cvd. Textbook Of Cardiology. Jaypee Brothers Medical Publishers (P) Ltd. 2022. Pages: 14-17.
30. Jps Sawhney, Vyom Mori, Saurabh Bagga, Kushal Madan. Dyslipidemia In Pregnancy. In : H.K. Chopra, Navin C. Nanda, Jagat Narula, Gs Wander, Cn Manjunath, Praveen Chandra, Viveka Kumar, Ck Ponde, Ak Pancholia (Eds). Advances In Statin Therapy & Beyond In Cvd. Textbook Of Cardiology. Jaypee Brothers Medical Publishers (P) Ltd. 2022. Pages:174-177
31. Hk Chopra, Ravi R Kasliwal, Jps Sawhney, Manish Bansal, Himani Malhotra. Current Place Of Rosuvastatin/Ezetimibe Combination In Management Of Hypercholesterolemia. In : H.K. Chopra, Navin C. Nanda, Jagat Narula, Gs Wander, Cn Manjunath, Praveen Chandra, Viveka Kumar, Ck Ponde, Ak Pancholia (Eds). Advances In Statin Therapy & Beyond In Cvd. Textbook Of Cardiology. Jaypee Brothers Medical Publishers (P) Ltd. 2022. Pages:76-80
National Lead Investigator In Global Clinical Trials:
1. Plato
2. Ethics Trial
3. Polypill
4. Hermes
5. Oceanic Af
National Lead Investigator In Global Clinical Registries:
1. Garfiled Af
2. Epicore
3. Diaysis Ii
Ongoing Clinical Trials As Principal Investigator
1. Remit Hf A Prospective Multicenter Randomized Open Label Active Controlled Study To Assess Effect Of Remogliflozin On Biomarkers Of Heart Failure Compared To Empagliflozin In Patients Of Type 2 Diabetes Mellitus With Chronic Heart Failure.
2. A Multinational, Randomized Open-Label, Parallel Group, Active-Controlled, Two-Arm, Long-Term Morbidity And Mortality Trial Involving Intensive Preventive Therapy (High Dose Renin-Angiotensin-Aldosterone System Inhibitors [Raasi], Beta-Blockade, Sodium-Glucose Co-Transporter 2 Inhibitors [Sglt2i]) Among Biomarker (N-Terminal Pro-B-Type Natriuretic Peptide, Nt-Probnp)-Identified High Risk Type 2 Dm Patients Without Pre-Existing Cardiovascular Disease"
3. Effect Of Semaglutide 2.4 Mg Once Weekly On Function And Symptoms In Subjects With Obesity Related Heart Failure With Preserved Ejection Fraction, And Type 2 Diabetes.
4. Protocol-"Relationship And Differences Between Central Aortic And Peripheral Blood Pressure Measurement Performed With The Same Device."
5. Effects Of Semaglutide On Functional Capacity In Patients With Type 2 Diabetes And Peripheral Arterial Disease (Stride).
6. Collaborative Quality Improvement (C-Qip) Study
7. A Phase 3, Prospective, Multicenter, Double-Blind, Double-Dummy, Randomized, Active Controlled, Parallel-Group, Group-Sequential, Adaptive, Event-Driven Study To Compare Efficacy, Safety, And Tolerability Of Macitentan 75 Mg Versus Macitentan 10 Mg In Patients With Pulmonary Arterial Hypertension, Followed By An Open-Label Treatment Period With Macitentan 75 Mg
8. A Phase Iv Study To Investigate The Safety And Effectiveness Of Rivaroxaban (Xarelto) 2.5mg [Bid] + Acetylsalicylic Acid (Asa) 75 Mg Od] In Indian Patients With Coronary And /Or Symptomatic Peripheral Artery Disease.
